Who owns PHOENIX BIOTECH ACQUISITION?
- Ticker: CEROW
- CUSIP Number: 71902k113
Tip: Access positions for across all investors
Analyze quarterly positions in Phoenix Biotech Acquisition with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Phoenix Biotech Acquisition stock
Who bought or sold PHOENIX BIOTECH ACQUISITION this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Highbridge Capital Management | 829k | $74M | 80% | Mar 2024 |
|
| Cowen And Company | 639k | $44k | 219% | Mar 2024 |
|
| Cantor Fitzgerald, L. P. | 441k | $35k | 21% | Mar 2024 |
|
| MMCAP International Inc. SPC | 375k | $26k | 0% | Mar 2024 |
|
| Saba Capital Management | 296k | $26k | 0% | Mar 2024 |
|
| Shaolin Capital Management | 268k | $18k | -29% | Mar 2024 |
|
| Atalaya Capital Management | 225k | $4.5M | 0% | Dec 2023 |
|
| Q Global Advisors | 171k | $12k | 0% | Mar 2024 |
|
| Clear Street | 144k | $10k | 60% | Mar 2024 |
|
| Context Capital Management | 122k | $8.3k | -39% | Mar 2024 |
|
| Millennium Management | 109k | $7.4k | 0% | Mar 2024 |
|
| Highland Capital Management Fund Advisors | 109k | $7.4k | 0% | Mar 2024 |
|
| Ionic Capital Management | 80k | $5.5k | 100% | Mar 2024 |
|
| Picton Mahoney Asset Management | 75k | $5.0k | 0% | Mar 2024 |
|
| Westchester Capital Management | 75k | $6.7k | 0% | Mar 2024 |
|
| Wolverine Asset Management | 64k | $4.4k | -27% | Mar 2024 |
|
| Kim | 50k | $3.4k | 0% | Mar 2024 |
|
| Tenor Capital Management | 50k | $3.4M | 0% | Mar 2024 |
|
| Yakira Capital Management | 50k | $3.4k | 0% | Mar 2024 |
|
| Hrt Financial | 36k | $3.0k | -1% | Mar 2024 |
|
| Whitebox Advisors | 25k | $1.7k | 0% | Mar 2024 |
|
| Rivernorth Capital Management | 25k | $1.7k | 0% | Mar 2024 |
|
| Walleye Trading Advisors | 24k | $1.6k | -8% | Mar 2024 |
|
| Schonfeld Strategic Advisors | 20k | $1.4k | -40% | Mar 2024 |
|
| Flow Traders US | 18k | $1.0k | -35% | Mar 2024 |
|
| Susquehanna International | 14k | $1.2k | 100% | Mar 2024 |
|
| Walleye Trading | 14k | $919.472400 | 0% | Mar 2024 |
|
| Calamos Advisors | 13k | $1.1k | 0% | Mar 2024 |
|
| DuPont Capital Management Corporation | 13k | $1.1k | 0% | Mar 2024 |
|
| Silver Rock Financial | 12k | $834k | 0% | Mar 2024 |
|
| Cubist Systematic Strategies | 11k | $716.100000 | -37% | Mar 2024 |
|
| Exos Asset Management | 3.7k | $251.970000 | 100% | Mar 2024 |
|
| Exos TFP Holdings | 3.7k | $92.870000 | 0% | Dec 2023 |
|
| Ancora Advisors | 2.5k | $170.000000 | 0% | Mar 2024 |
|
| Robinson Capital Management | 1.0k | $24.000000 | -10% | Dec 2023 |
|
| Bank of America Corporation | 200.00 | $14.000000 | 0% | Mar 2024 |
|
| Pineridge Advisors | 150.00 | $10.005000 | 100% | Mar 2024 |
|
| Tower Research Capital | 87.00 | $6.003000 | 100% | Mar 2024 |
|
Who sold out of Phoenix Biotech Acquisition?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Polar Securities | Dec 2023 | 300k | $8.3k |
| Linden Advisors | Sep 2023 | 250k | $19M |
| CNH Partners | Dec 2023 | 247k | $5.8k |
| Castle Creek Arbitrage | Sep 2023 | 200k | $14k |
| CVI Holdings | Sep 2023 | 44k | $3.2M |
| Spartan Fund Management | Dec 2023 | 25k | $687.500000 |
| Parallax Volatility Advisers | Dec 2023 | 15k | $398.805000 |
| Segantii Capital Management | Dec 2023 | 5.0k | $55k |